Current role
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
Joel Latham
Board Member
Incannex Healthcare Inc. (IXHL)Equibles does not estimate personal net worth.
Get an email with a short summary when Incannex Healthcare Inc. publishes a filing, an earnings call transcript or a press release.
Get IXHL alertsAbout Joel Latham
Joel Latham is recorded as CEO and Board Member at Incannex Healthcare Inc. (IXHL). The newest filing on record that lists Joel Latham as CEO and Board Member at Incannex Healthcare Inc. (IXHL) is dated October 28, 2026. The proxy statement of Incannex Healthcare Inc. reports total compensation of $6,527,200 for Joel Latham in fiscal 2026, including a base salary of $790,000. Disclosed compensation is on record for 3 fiscal years. Incannex Healthcare Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Incannex Healthcare Inc. includes Joseph Swan (CFO), Lekhram Changoer (CTO), Dr. George Anastassov (Board Member) and 2 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed October 28, 2026
-
Current
Start not stated–present
Last confirmed October 28, 2026
Company network
Leadership on record at Incannex Healthcare Inc.
- Joseph Swan CFO
- Lekhram Changoer CTO
- Dr. George Anastassov Board Member
- Peter Widdows Board Member
- Robert Clark Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Incannex Healthcare Inc. (IXHL) | Chief Executive Officer | $790,000 | $6,527,200 |
| 2025 | Incannex Healthcare Inc. (IXHL) | Chief Executive Officer | $656,464 | $1,125,050 |
| 2024 | Incannex Healthcare Inc. (IXHL) | Chief Executive Officer | $595,958 | $6,216,082 |
Recent activity
No call appearances or filed executive changes recorded yet.